Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 9/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7185010 | 1.00 | ELANE (0.43) | ELANEABCG2PTPN1PDE4APDE4B | |
| SCHEMBL7184634 | 0.89 | ELANE (0.41) | ELANEABCG2PTPN1PDE4APDE4B | |
| SCHEMBL7184638 | 0.89 | ELANE (0.41) | ELANEABCG2PTPN1PDE4APDE4B | |
| SCHEMBL7185125 | 0.87 | PPARA (0.38) | ABCG2PTPN1PDE4APDE4BPDE4C | |
| SCHEMBL7185131 | 0.87 | PPARA (0.38) | ABCG2PTPN1PDE4APDE4BPDE4C | |
| SCHEMBL7189198 | 0.87 | ELANE (0.45) | ELANEABCG2PTPN1BCHE | |
| SCHEMBL7189192 | 0.87 | ELANE (0.45) | ELANEABCG2PTPN1BCHE | |
| SCHEMBL7185651 | 0.86 | ABCG2 (0.52) | ELANEABCG2PTPN1 | |
| SCHEMBL7185654 | 0.86 | ABCG2 (0.52) | ELANEABCG2PTPN1 | |
| SCHEMBL7178970 | 0.86 | ELANE (0.38) | ELANEABCG2PTPN1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | disclosed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | disclosed |
| US-5985935-A | PARASITICIDES OR BACTERICIDES | STATENS SERUMINSTITUT (DK) | 1999-11-16 | — | — | US | disclosed |
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | disclosed |